Amgen News

Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.

Interested in finding undervalued stocks? For ideas on where to look, we ran a screen you might be interested in.

Johnson & Johnson , Pfizer Inc. A ,A Amgen, Inc. A : The FDA released guidelines for the first shortcut to the U.S. market for "biosimilar" drugs, less expensive versions of expensive and complex medicines made from biological matter.

Tallahassee, FL 2/10/12 - Biotechnology topics are hot in the investment community.

Koch said personalized medicine involves knowing the molecular pathophysiology of the patient's disease and differentially diagnosing the disease on the basis of those underlying molecular defects.

All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights and analysis in real-time on Minyanville's Buzz & Banter .

Amgen was downgraded by research analysts at Oppenheimer from an "outperform" rating to a "perform" rating in a report issued on Thursday.

The Food and Drug Administration on Thursday created the first shortcut to the U.S. market for "biosimilar" drugs - cheaper versions of expensive and complex medicines made from biological matter.

Recent earnings reports from a few bellwethers in the pharmaceutical space suggest that more pain is likely ahead for the beleaguered industry.

Amgen, Inc. is discussing data from its supplemental Biologics License Application for Xgeva to treat men with castration-resistant prostate cancer at high risk of developing bone metastases at today's FDA's Oncologic Drugs Advisory Committee meeting.

An initial public offering of a tiny slice of Caesars Entertainment Corp. is allowing dozens of investors who bought into what once was the world's largest gambling company to get out -- perhaps with smaller losses than they might have seen.

Sanofi's fourth quarter income of Genzyme and emerging markets offsets the death of patents and the effect of European Union rigor.

A panel of cancer experts voted against a new use for Amgen 's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients The Food and Drug Administration 's cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its risks, which ... (more)

Medgenics has, what I believe to be, the most disruptive biotechnologies of the last 20 years.

Amgen will discuss the data from the supplemental Biologics License Application for XGEVA to treat men with castration-resistant prostate cancer at high risk of developing bone metastases at today's meeting of the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee .

Amgen was upgraded by Zacks Investment Research from a "neutral" rating to an "outperform" rating in a research note issued to investors on Tuesday.

Binswanger and Kidder Mathews Named Exclusive Agent for Sublease of Class A Lab and Office Space in South San Francisco, California PHILADELPHIA, PA -- -- 02/07/12 -- Binswanger and Kidder Mathews have been named exclusive agents by Amgen, Inc.

Sprint Nextel Corp. : FBR's channel checks indicate Sprint's solid execution continues and the firm reiterates an Outperform rating on the stock ahead of the company's Q4 results on February 8. FBR believes Sprint is on track to exceed consensus expectations in FY12.

Orexigen Therapeutics announced that it has reached agreement with the U.S. FDA on a Special Protocol Assessment, or SPA, for the Contrave outcomes trial.

Amgen was downgraded by investment analysts at Lazard Capital from a "neutral" rating to a "sell" rating in a note issued to investors on Monday.